Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1058 |
|---|---|
| Identifier | NCT05633771 |
| Trial Title | Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | OTHER: Hyrimoz |
Participant Information
| Sponsor | Sandoz |
|---|---|
| City | Aalst |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2023-02-16 |
|---|---|
| Primary Completion Date | 2025-12-15 |
| Completion Date | 2026-12 |